Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
16m agoInterContinental Hotels Group PLC Announces Transaction in Own Shares - April 30
17m agoMiscellaneous
20m agoQuarterly Activities Report - March 2026
50m agoAppendix 4C and Quarterly Activities Report - March 2026
1h agoDiagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
Lantheus Holdings Inc logo

Lantheus Holdings Inc

About

Lantheus Holdings Inc (NASDAQ:LNTH) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 23 2026
Lantheus to Host First Quarter 2026 Earnings Conference Call and Webcast on May 7, 2026, at 8:00 a.m. Eastern Time
Mar 17 2026
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
Mar 6 2026
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
Mar 2 2026
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
Feb 26 2026
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Financials

Revenue
$1.54 B
Market Cap
$4.95 B
P/E Ratio
22.32
EPS
3.41

Community Chat

Ask AI

6ix6ix